NL-OMON42320招募中不适用
Treatment of chronic hepatitis C infection with direct acting antivirals: effects on liver fibrosis and patient reported outcomes - DURACE study
Afdeling Maag-, Darm en Leverziekten0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- Chronic hepatitis C
- •- Age > 18 years
- •- METAVIR score F3-F4 (classified by liver biopsy or Fibroscan score >9,5 kPa)
- •- Status after liver transplantation or on the waiting list for liver transplantation
- •- Severe extra hepatic disease (HCV-related skin disease like prophyria cutanea tarda or leukocytoclastic vasculitis; or HCV related renal impairment secondary to cryoglobulinemia
排除标准
- •- Patients who don't meet the criteria for DAA treatment
- •- Patients who are not able to visit the outpatient clinic at regular basis
研究者
相似试验
进行中（未招募）
不适用
Evaluation of chronic hepatitis C treatment with PEG-IFN ALFA-2a and ribavirin in HIV-positive subjects with persistently normal transaminase levels. - Treatment of co-infected patients with normal ALTTreatment of adult patients with hystologically demonstrated chronic C hepatitis without hepatic failure and HCV-RNA positive, treatment of patients with normal ALT and with HIV/HCV co-infection.MedDRA version: 9.1Level: LLTClassification code 10019744Term: Hepatitis CEUCTR2007-005698-76-ITAZIENDA OSPEDALIERA L. SACCO (A.O. DI RILIEVO NAZIONALE)
进行中（未招募）
1 期
Direct acting antiviral therapy of hepatitis C in Denmark: treatment response, adverse events and resistance associated variantsPatients with chronic hepatitis CMedDRA version: 19.1Level: LLTClassification code 10074391Term: Chronic hepatitis C virus genotype 1System Organ Class: 100000004862EUCTR2015-001956-31-DKDepartment of Infectious Diseases, Copenhagen University Hospital, Hvidovre.111
已完成
不适用
Retreatment of hepatitis C non-responsive to Interferon: a placebo controlled randomised trial of Ribavirin monotherapy versus combination therapy with Ribavirin and Interferon in 121 patients in the BeneluxChronic hepatitis CInfections and InfestationsHepatitisISRCTN53821378Schering Plough International (USA)117
已完成
2 期
A pilot phase II open-label study of oglufanide disodium in patients with chronic hepatitis CChronic hepatitis CInfection - Other infectious diseasesACTRN12607000418471Implicit Bioscience Pty Ltd17
已完成
不适用
TREATMENT OF PATIENTS WITH CHRONIC HEPATITIS C (HCC) USING PEG-INTERFERON ALPHA 2B AND RIBAVIRINEPER-039-01SCHERING PLOUGH RESEARCH INSTITUTE,